Find News

Filter articles

Applied Filters

Showing 21 to 30 of 129 results

Samsung to make $22bn investment in new technology

South Korea10-08-2018

South Korea-based Samsung has revealed plans to commit W25 trillion to pursue new technology in areas including biopharmaceuticals and artificial intelligence.

Sanofi to launch €66m R&D hub in China


France-based Sanofi has announced plans to launch a research and development hub in China to focus on digitalisation and big data analysis.

Australia’s competition regulator seeks to appeal Pfizer judgment


The Australian Competition and Consumer Commission said yesterday that it has sought to appeal against a decision by the Full Federal Court of Australia in a case involving Pfizer.

MSF challenges Gilead patent in China


Humanitarian organisation Médecins Sans Frontières has challenged a patent owned by Gilead in China.

Chinese company fund invests in AI specialist

China, US13-06-2018

China-based pharmaceutical technology company WuXi AppTec has partnered with artificial intelligence specialist Insilico Medicine to integrate Insilico’s AI technology with WuXi’s laboratory infrastructure.

Pfizer’s generic deals don’t violate competition law, says Australian court


A court has rejected an appeal by the Australian Competition and Consumer Commission, in a decision which confirmed that deals made by Pfizer in relation to generic cholesterol-lowering medication do not constitute a misuse of its market power.

Astellas-backed Crescendo pairs up with Zai Lab in licensing deal

China, UK31-05-2018

UK-based Crescendo Biologics has agreed a global licensing deal with biopharma company Zai Lab which will see Zai Lab develop and commercialise an antibody, “VH domain therapeutic”, for applications in inflammatory diseases. 

Apotex and Strides to merge Australia generics business


Canadian generics maker Apotex and India-based Strides Shasun will merge their Australian operations in a bid to create the leading player in the Australian generics pharmaceutical market.

AstraZeneca sells Seroquel rights for $538m

China, UK10-05-2018

AstraZeneca has agreed to sell its rights to Seroquel (quetiapine fumarate) and Seroquel XR to China-based pharmaceutical company Luye Pharma Group for $538 million.

Celgene drops trademark claim against online pharmacies

India, US10-05-2018

Biopharmaceutical company Celgene has ditched its trademark quarrel with the owners of India-based online pharmacies importing generics into the US.

Showing 21 to 30 of 129 results